Pharmacological characterization of metabotropic glutamate receptors in cultured cerebellar granule cells - PubMed (original) (raw)

Pharmacological characterization of metabotropic glutamate receptors in cultured cerebellar granule cells

E Aronica et al. Neurochem Res. 1993 May.

Abstract

A detailed pharmacological characterization of metabotropic glutamate receptors (mGluR) was performed in primary cultures of cerebellar granule cells at 6 days in vitro (DIV). The rank order of agonists induced polyphosphoinositide (PPI) hydrolysis (after correcting for the ionotropic component in the response) was as follows: in terms of efficiency, Glu > quisqualate (quis) = ibotenate (ibo) > (1S,3R)-1-amino-cyclopentane-1,3-dicarboxylic acid (ACPD) > beta-methyl-amino-L-alanine (BMAA) and in terms of potency, quis > ACPD > Glu > ibo = BMAA. Ionotropic excitatory amino acid (EAA) receptor agonists, such as alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) and N-methyl-D-aspartate (NMDA) were relatively inactive (in the presence of Mg2+). Quis and ACPD-induced PPI hydrolysis was unaffected by ionotropic Glu receptor antagonists, but was inhibited, in part by L-2-amino-3-phosphonopropionate (AP3). In contrast, Glu-or ibo- induced PPI hydrolysis was reduced, in part, by both AP3 and NMDA receptor antagonists. Characteristic interactions involving different transmitter receptors were noted. PPI hydrolysis evoked by quis and 1S,3R-ACPD was not additive. In contrast, PPI hydrolysis stimulated by quis/ACPD and carbamylcholine was additive (indicating different receptors/transduction pathways). In the presence of Mg2+, the metabotropic response to quis/AMPA and NMDA was synergistic (this being consistent with AMPA receptor-induced depolarization activating NMDA receptor). On the other hand, in Mg(2+)-free buffer the effects of quis and NMDA, at concentrations causing maximal PPI hydrolysis, were additive (indicating that PPI hydrolysis was effected by two different mechanisms).(ABSTRACT TRUNCATED AT 250 WORDS)

PubMed Disclaimer

Similar articles

• Excitatory amino acid receptor-stimulated phosphoinositide turnover in primary cerebrocortical cultures.
  Birrell GJ, Marcoux FW. Birrell GJ, et al. Br J Pharmacol. 1993 Jun;109(2):379-85. doi: 10.1111/j.1476-5381.1993.tb13580.x. Br J Pharmacol. 1993. PMID: 8395285 Free PMC article.
• A metabotropic L-glutamate receptor agonist: pharmacological difference between rat central neurones and crayfish neuromuscular junctions.
  Shinozaki H, Ishida M. Shinozaki H, et al. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1992 Sep;103(1):13-7. doi: 10.1016/0742-8413(92)90220-2. Comp Biochem Physiol C Comp Pharmacol Toxicol. 1992. PMID: 1360366 Review.
• Metabotropic glutamate receptors in brain function and pathology.
  Schoepp DD, Conn PJ. Schoepp DD, et al. Trends Pharmacol Sci. 1993 Jan;14(1):13-20. doi: 10.1016/0165-6147(93)90107-u. Trends Pharmacol Sci. 1993. PMID: 7680175 Review.

Cited by

• Models of calcium dynamics in cerebellar granule cells.
  Saftenku EÈ. Saftenku EÈ. Cerebellum. 2012 Mar;11(1):85-101. doi: 10.1007/s12311-010-0216-3. Cerebellum. 2012. PMID: 20922512 Review.
• Type 2 metabotropic glutamate receptor (mGluR2) fails to negatively couple to cGMP in stably transfected cells.
  Wroblewska B, Wegorzewska IN, Bzdega T, Neale JH. Wroblewska B, et al. Neurochem Int. 2011 Feb;58(2):176-9. doi: 10.1016/j.neuint.2010.11.012. Epub 2010 Nov 27. Neurochem Int. 2011. PMID: 21115084 Free PMC article.
• Deficits in ventromedial prefrontal cortex group 1 metabotropic glutamate receptor function mediate resistance to extinction during protracted withdrawal from an extensive history of cocaine self-administration.
  Ben-Shahar O, Sacramento AD, Miller BW, Webb SM, Wroten MG, Silva HE, Caruana AL, Gordon EJ, Ploense KL, Ditzhazy J, Kippin TE, Szumlinski KK. Ben-Shahar O, et al. J Neurosci. 2013 Jan 9;33(2):495-506a. doi: 10.1523/JNEUROSCI.3710-12.2013. J Neurosci. 2013. PMID: 23303930 Free PMC article.
• The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease.
  Tsai VW, Scott HL, Lewis RJ, Dodd PR. Tsai VW, et al. Neurotox Res. 2005;7(1-2):125-41. doi: 10.1007/BF03033782. Neurotox Res. 2005. PMID: 15639804 Review.

References

1. 1. Trends Neurosci. 1988 Dec;11(12):545-9 - PubMed
2. 1. J Neurochem. 1987 Mar;48(3):967-73 - PubMed
3. 1. Eur J Pharmacol. 1991 Jul 12;207(3):231-41 - PubMed
4. 1. Neuron. 1992 Jan;8(1):169-79 - PubMed
5. 1. Prog Neurobiol. 1987;28(3):197-276 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database